Canbiola, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by DILLEY CARL, was filed 12 Feb 2018.
Canbiola, Inc.: what insiders have been doing
This page follows insider dealings at Canbiola, Inc. as filed with SEC (Form 4). The past year has been quiet: not a single insider filing for Canbiola, Inc. The previous disclosure was published on 5 August 2019.
Our records for Canbiola, Inc. go back to 2018, with 1 purchase and 2 sales on the open market in total.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2023FY ended December 2023 · cache
- 50,000 shares@ US$0.02950.0% of flowCanbiolaSEC:0001700986-19-000003:0
- 50,000 shares@ US$0.02950.0% of flowCanbiolaSEC:0001700986-19-000003:1
- 3,000,000 shares0Common StockSEC:0001511164-18-000077:0Canonical exit: 10 May 2018 (T+90)
3 of 3 declarations
About Canbiola, Inc.
Canbiola, Inc. is a company listed on the XNAS market, specializing in the development of cannabidiol-based products. It focuses on research and marketing of cannabis-based wellness solutions.
